Page not found

Search results

  1. mGlu3 NAMs as Therapeutics for Chemoresistant Tumors

    ... related to survival in patients with malignant gliomas (Cell Death and Differentiation, 2012, 1-12). The mechanism has been further ...

    cttc_admin - 01/23/2024 - 4:42pm

  2. Technology Disclosure FAQs

    ... of intellectual property, and each form differs based on the type of information needed for CTTC to evaluate the technology and to fulfill ... For Research Tools - often a plasmid, mouse model, cell line, or other common tool used in the lab – we have our concise ...

    mullerg - 03/16/2023 - 11:38am

  3. Rabbit-Anti-mouse Pancreatic and Duodenal Homebox Gene-1 Antibody

    ... Use: Developmental Biology/Stem Cell Metabolic Disorders/ Diabetes Research Tool Type: Assays/Screening ...

    cttc_admin - 05/31/2023 - 1:58pm

  4. Prevention of Cytokine Induced Apoptosis In Intestinal Epithelial Cells By A Probiotic Bacterium

    ... maintaining intestinal homeostasis by decreasing epithelial cell injury and inhibiting inflammatory responses in intestinal epithelial ... Research Tool Type: Protein/Peptide ...

    cttc_admin - 05/31/2023 - 1:55pm

  5. Miniature Magnetorheological Brake Technology

    ... We are currently seeking a partner for commercializing this product for various applications. Figure 1: The size of the actual ...

    cttc_admin - 10/30/2023 - 9:56am

  6. Novel Approaches to Increase Morbillibirus Yield from Eukaryotic Cells Culture

    ... the propagation of viruses in vitro using eukaryotic cell cultures. Increasing the viral yield during in vitro viral cultivation is ...

    cttc_admin - 11/07/2023 - 3:32pm

  7. Innovation Catalyst Fund Application Preview

    ... Predicted Outcome – brief description of the product or process to be developed as an end goal of the funding ...

    cttc_admin - 10/04/2023 - 4:35pm

  8. Long-Lasting and Self-Sustaining Cell Therapy System

    Summary Current T-cell therapies rely on the successful transplant and survival of infused, therapeutic cells in a patient. The efficacy of a cell therapy is limited by the extent of cell survival after adoptive cell transfer (ACT) and by the stability of the ...

    cttc_admin - 07/05/2023 - 9:22am

  9. IRB & FDA Support

    ... MPSS can assess the regulatory requirements for your product, whether the goal is a clinical study or bringing the product to the market. We also collaborate with the Vanderbilt IRB, to support ...

    mullerg - 09/30/2016 - 8:40am

  10. Commercialization Support

    ... MPSS can help with strategies for bringing your medical product (pharmaceutical, medical device, or diagnostic) to the market. Through ... bringing your pharmaceutical, medical device, or diagnostic product to market Development of strategies for development, test data, ...

    mullerg - 09/30/2016 - 8:44am